Global Sleeping Pills (Prescription Drugs) Market Insights and Forecast to 2028

Report ID: 1126813 | Published Date: Jan 2025 | No. of Page: 110 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Sleeping Pills (Prescription Drugs) Product Introduction
    1.2 Market by Type
        1.2.1 Global Sleeping Pills (Prescription Drugs) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Zolpidem
        1.2.3 Eszopiclone (Lunesta)
        1.2.4 Ramelteon (Rozerem)
        1.2.5 Ativan (lorazepam)
        1.2.6 Adapin (doxepin)
    1.3 Market by Application
        1.3.1 Global Sleeping Pills (Prescription Drugs) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacy
        1.3.3 Retail Pharmacy
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Sleeping Pills (Prescription Drugs) Sales Estimates and Forecasts 2017-2028
    2.2 Global Sleeping Pills (Prescription Drugs) Revenue Estimates and Forecasts 2017-2028
    2.3 Global Sleeping Pills (Prescription Drugs) Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Sleeping Pills (Prescription Drugs) Sales by Region
        2.4.1 Global Sleeping Pills (Prescription Drugs) Sales by Region (2017-2022)
        2.4.2 Global Sales Sleeping Pills (Prescription Drugs) by Region (2023-2028)
    2.5 Global Sleeping Pills (Prescription Drugs) Revenue by Region
        2.5.1 Global Sleeping Pills (Prescription Drugs) Revenue by Region (2017-2022)
        2.5.2 Global Sleeping Pills (Prescription Drugs) Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Sleeping Pills (Prescription Drugs) Sales by Manufacturers
        3.1.1 Global Top Sleeping Pills (Prescription Drugs) Manufacturers by Sales (2017-2022)
        3.1.2 Global Sleeping Pills (Prescription Drugs) Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Sleeping Pills (Prescription Drugs) in 2021
    3.2 Global Sleeping Pills (Prescription Drugs) Revenue by Manufacturers
        3.2.1 Global Sleeping Pills (Prescription Drugs) Revenue by Manufacturers (2017-2022)
        3.2.2 Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Sleeping Pills (Prescription Drugs) Revenue in 2021
    3.3 Global Sleeping Pills (Prescription Drugs) Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Sleeping Pills (Prescription Drugs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Sleeping Pills (Prescription Drugs) Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Sleeping Pills (Prescription Drugs) Sales by Type
        4.1.1 Global Sleeping Pills (Prescription Drugs) Historical Sales by Type (2017-2022)
        4.1.2 Global Sleeping Pills (Prescription Drugs) Forecasted Sales by Type (2023-2028)
        4.1.3 Global Sleeping Pills (Prescription Drugs) Sales Market Share by Type (2017-2028)
    4.2 Global Sleeping Pills (Prescription Drugs) Revenue by Type
        4.2.1 Global Sleeping Pills (Prescription Drugs) Historical Revenue by Type (2017-2022)
        4.2.2 Global Sleeping Pills (Prescription Drugs) Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Type (2017-2028)
    4.3 Global Sleeping Pills (Prescription Drugs) Price by Type
        4.3.1 Global Sleeping Pills (Prescription Drugs) Price by Type (2017-2022)
        4.3.2 Global Sleeping Pills (Prescription Drugs) Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Sleeping Pills (Prescription Drugs) Sales by Application
        5.1.1 Global Sleeping Pills (Prescription Drugs) Historical Sales by Application (2017-2022)
        5.1.2 Global Sleeping Pills (Prescription Drugs) Forecasted Sales by Application (2023-2028)
        5.1.3 Global Sleeping Pills (Prescription Drugs) Sales Market Share by Application (2017-2028)
    5.2 Global Sleeping Pills (Prescription Drugs) Revenue by Application
        5.2.1 Global Sleeping Pills (Prescription Drugs) Historical Revenue by Application (2017-2022)
        5.2.2 Global Sleeping Pills (Prescription Drugs) Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Application (2017-2028)
    5.3 Global Sleeping Pills (Prescription Drugs) Price by Application
        5.3.1 Global Sleeping Pills (Prescription Drugs) Price by Application (2017-2022)
        5.3.2 Global Sleeping Pills (Prescription Drugs) Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Sleeping Pills (Prescription Drugs) Market Size by Type
        6.1.1 North America Sleeping Pills (Prescription Drugs) Sales by Type (2017-2028)
        6.1.2 North America Sleeping Pills (Prescription Drugs) Revenue by Type (2017-2028)
    6.2 North America Sleeping Pills (Prescription Drugs) Market Size by Application
        6.2.1 North America Sleeping Pills (Prescription Drugs) Sales by Application (2017-2028)
        6.2.2 North America Sleeping Pills (Prescription Drugs) Revenue by Application (2017-2028)
    6.3 North America Sleeping Pills (Prescription Drugs) Market Size by Country
        6.3.1 North America Sleeping Pills (Prescription Drugs) Sales by Country (2017-2028)
        6.3.2 North America Sleeping Pills (Prescription Drugs) Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Sleeping Pills (Prescription Drugs) Market Size by Type
        7.1.1 Europe Sleeping Pills (Prescription Drugs) Sales by Type (2017-2028)
        7.1.2 Europe Sleeping Pills (Prescription Drugs) Revenue by Type (2017-2028)
    7.2 Europe Sleeping Pills (Prescription Drugs) Market Size by Application
        7.2.1 Europe Sleeping Pills (Prescription Drugs) Sales by Application (2017-2028)
        7.2.2 Europe Sleeping Pills (Prescription Drugs) Revenue by Application (2017-2028)
    7.3 Europe Sleeping Pills (Prescription Drugs) Market Size by Country
        7.3.1 Europe Sleeping Pills (Prescription Drugs) Sales by Country (2017-2028)
        7.3.2 Europe Sleeping Pills (Prescription Drugs) Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Sleeping Pills (Prescription Drugs) Market Size by Type
        8.1.1 Asia Pacific Sleeping Pills (Prescription Drugs) Sales by Type (2017-2028)
        8.1.2 Asia Pacific Sleeping Pills (Prescription Drugs) Revenue by Type (2017-2028)
    8.2 Asia Pacific Sleeping Pills (Prescription Drugs) Market Size by Application
        8.2.1 Asia Pacific Sleeping Pills (Prescription Drugs) Sales by Application (2017-2028)
        8.2.2 Asia Pacific Sleeping Pills (Prescription Drugs) Revenue by Application (2017-2028)
    8.3 Asia Pacific Sleeping Pills (Prescription Drugs) Market Size by Region
        8.3.1 Asia Pacific Sleeping Pills (Prescription Drugs) Sales by Region (2017-2028)
        8.3.2 Asia Pacific Sleeping Pills (Prescription Drugs) Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Sleeping Pills (Prescription Drugs) Market Size by Type
        9.1.1 Latin America Sleeping Pills (Prescription Drugs) Sales by Type (2017-2028)
        9.1.2 Latin America Sleeping Pills (Prescription Drugs) Revenue by Type (2017-2028)
    9.2 Latin America Sleeping Pills (Prescription Drugs) Market Size by Application
        9.2.1 Latin America Sleeping Pills (Prescription Drugs) Sales by Application (2017-2028)
        9.2.2 Latin America Sleeping Pills (Prescription Drugs) Revenue by Application (2017-2028)
    9.3 Latin America Sleeping Pills (Prescription Drugs) Market Size by Country
        9.3.1 Latin America Sleeping Pills (Prescription Drugs) Sales by Country (2017-2028)
        9.3.2 Latin America Sleeping Pills (Prescription Drugs) Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Sleeping Pills (Prescription Drugs) Market Size by Type
        10.1.1 Middle East and Africa Sleeping Pills (Prescription Drugs) Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Sleeping Pills (Prescription Drugs) Revenue by Type (2017-2028)
    10.2 Middle East and Africa Sleeping Pills (Prescription Drugs) Market Size by Application
        10.2.1 Middle East and Africa Sleeping Pills (Prescription Drugs) Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Sleeping Pills (Prescription Drugs) Revenue by Application (2017-2028)
    10.3 Middle East and Africa Sleeping Pills (Prescription Drugs) Market Size by Country
        10.3.1 Middle East and Africa Sleeping Pills (Prescription Drugs) Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Sleeping Pills (Prescription Drugs) Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Sanofi
        11.1.1 Sanofi Corporation Information
        11.1.2 Sanofi Overview
        11.1.3 Sanofi Sleeping Pills (Prescription Drugs) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Sanofi Sleeping Pills (Prescription Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Sanofi Recent Developments
    11.2 Abbott Laboratories
        11.2.1 Abbott Laboratories Corporation Information
        11.2.2 Abbott Laboratories Overview
        11.2.3 Abbott Laboratories Sleeping Pills (Prescription Drugs) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Abbott Laboratories Sleeping Pills (Prescription Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Abbott Laboratories Recent Developments
    11.3 Takeda Pharmaceutical
        11.3.1 Takeda Pharmaceutical Corporation Information
        11.3.2 Takeda Pharmaceutical Overview
        11.3.3 Takeda Pharmaceutical Sleeping Pills (Prescription Drugs) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Takeda Pharmaceutical Sleeping Pills (Prescription Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Takeda Pharmaceutical Recent Developments
    11.4 Apotex
        11.4.1 Apotex Corporation Information
        11.4.2 Apotex Overview
        11.4.3 Apotex Sleeping Pills (Prescription Drugs) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Apotex Sleeping Pills (Prescription Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Apotex Recent Developments
    11.5 Aurobindo Pharma
        11.5.1 Aurobindo Pharma Corporation Information
        11.5.2 Aurobindo Pharma Overview
        11.5.3 Aurobindo Pharma Sleeping Pills (Prescription Drugs) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Aurobindo Pharma Sleeping Pills (Prescription Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Aurobindo Pharma Recent Developments
    11.6 Actellon Pharmaceuticals
        11.6.1 Actellon Pharmaceuticals Corporation Information
        11.6.2 Actellon Pharmaceuticals Overview
        11.6.3 Actellon Pharmaceuticals Sleeping Pills (Prescription Drugs) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Actellon Pharmaceuticals Sleeping Pills (Prescription Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Actellon Pharmaceuticals Recent Developments
    11.7 Allegiant Health
        11.7.1 Allegiant Health Corporation Information
        11.7.2 Allegiant Health Overview
        11.7.3 Allegiant Health Sleeping Pills (Prescription Drugs) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Allegiant Health Sleeping Pills (Prescription Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Allegiant Health Recent Developments
    11.8 Cayman Chemical
        11.8.1 Cayman Chemical Corporation Information
        11.8.2 Cayman Chemical Overview
        11.8.3 Cayman Chemical Sleeping Pills (Prescription Drugs) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Cayman Chemical Sleeping Pills (Prescription Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Cayman Chemical Recent Developments
    11.9 Ambitropin
        11.9.1 Ambitropin Corporation Information
        11.9.2 Ambitropin Overview
        11.9.3 Ambitropin Sleeping Pills (Prescription Drugs) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Ambitropin Sleeping Pills (Prescription Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Ambitropin Recent Developments
    11.10 Hayao
        11.10.1 Hayao Corporation Information
        11.10.2 Hayao Overview
        11.10.3 Hayao Sleeping Pills (Prescription Drugs) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Hayao Sleeping Pills (Prescription Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Hayao Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Sleeping Pills (Prescription Drugs) Industry Chain Analysis
    12.2 Sleeping Pills (Prescription Drugs) Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Sleeping Pills (Prescription Drugs) Production Mode & Process
    12.4 Sleeping Pills (Prescription Drugs) Sales and Marketing
        12.4.1 Sleeping Pills (Prescription Drugs) Sales Channels
        12.4.2 Sleeping Pills (Prescription Drugs) Distributors
    12.5 Sleeping Pills (Prescription Drugs) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Sleeping Pills (Prescription Drugs) Industry Trends
    13.2 Sleeping Pills (Prescription Drugs) Market Drivers
    13.3 Sleeping Pills (Prescription Drugs) Market Challenges
    13.4 Sleeping Pills (Prescription Drugs) Market Restraints
14 Key Findings in The Global Sleeping Pills (Prescription Drugs) Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Sleeping Pills (Prescription Drugs) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Zolpidem
    Table 3. Major Manufacturers of Eszopiclone (Lunesta)
    Table 4. Major Manufacturers of Ramelteon (Rozerem)
    Table 5. Major Manufacturers of Ativan (lorazepam)
    Table 6. Major Manufacturers of Adapin (doxepin)
    Table 7. Global Sleeping Pills (Prescription Drugs) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Sleeping Pills (Prescription Drugs) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 9. Global Sleeping Pills (Prescription Drugs) Sales by Region (2017-2022) & (K Units)
    Table 10. Global Sleeping Pills (Prescription Drugs) Sales Market Share by Region (2017-2022)
    Table 11. Global Sleeping Pills (Prescription Drugs) Sales by Region (2023-2028) & (K Units)
    Table 12. Global Sleeping Pills (Prescription Drugs) Sales Market Share by Region (2023-2028)
    Table 13. Global Sleeping Pills (Prescription Drugs) Revenue by Region (2017-2022) & (US$ Million)
    Table 14. Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Region (2017-2022)
    Table 15. Global Sleeping Pills (Prescription Drugs) Revenue by Region (2023-2028) & (US$ Million)
    Table 16. Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Region (2023-2028)
    Table 17. Global Sleeping Pills (Prescription Drugs) Sales by Manufacturers (2017-2022) & (K Units)
    Table 18. Global Sleeping Pills (Prescription Drugs) Sales Share by Manufacturers (2017-2022)
    Table 19. Global Sleeping Pills (Prescription Drugs) Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 20. Global Sleeping Pills (Prescription Drugs) Revenue Share by Manufacturers (2017-2022)
    Table 21. Sleeping Pills (Prescription Drugs) Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 22. Global Sleeping Pills (Prescription Drugs) Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Sleeping Pills (Prescription Drugs) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sleeping Pills (Prescription Drugs) as of 2021)
    Table 24. Sleeping Pills (Prescription Drugs) Manufacturing Base Distribution and Headquarters
    Table 25. Manufacturers Sleeping Pills (Prescription Drugs) Product Offered
    Table 26. Date of Manufacturers Enter into Sleeping Pills (Prescription Drugs) Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Sleeping Pills (Prescription Drugs) Sales by Type (2017-2022) & (K Units)
    Table 29. Global Sleeping Pills (Prescription Drugs) Sales by Type (2023-2028) & (K Units)
    Table 30. Global Sleeping Pills (Prescription Drugs) Sales Share by Type (2017-2022)
    Table 31. Global Sleeping Pills (Prescription Drugs) Sales Share by Type (2023-2028)
    Table 32. Global Sleeping Pills (Prescription Drugs) Revenue by Type (2017-2022) & (US$ Million)
    Table 33. Global Sleeping Pills (Prescription Drugs) Revenue by Type (2023-2028) & (US$ Million)
    Table 34. Global Sleeping Pills (Prescription Drugs) Revenue Share by Type (2017-2022)
    Table 35. Global Sleeping Pills (Prescription Drugs) Revenue Share by Type (2023-2028)
    Table 36. Sleeping Pills (Prescription Drugs) Price by Type (2017-2022) & (USD/Unit)
    Table 37. Global Sleeping Pills (Prescription Drugs) Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 38. Global Sleeping Pills (Prescription Drugs) Sales by Application (2017-2022) & (K Units)
    Table 39. Global Sleeping Pills (Prescription Drugs) Sales by Application (2023-2028) & (K Units)
    Table 40. Global Sleeping Pills (Prescription Drugs) Sales Share by Application (2017-2022)
    Table 41. Global Sleeping Pills (Prescription Drugs) Sales Share by Application (2023-2028)
    Table 42. Global Sleeping Pills (Prescription Drugs) Revenue by Application (2017-2022) & (US$ Million)
    Table 43. Global Sleeping Pills (Prescription Drugs) Revenue by Application (2023-2028) & (US$ Million)
    Table 44. Global Sleeping Pills (Prescription Drugs) Revenue Share by Application (2017-2022)
    Table 45. Global Sleeping Pills (Prescription Drugs) Revenue Share by Application (2023-2028)
    Table 46. Sleeping Pills (Prescription Drugs) Price by Application (2017-2022) & (USD/Unit)
    Table 47. Global Sleeping Pills (Prescription Drugs) Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 48. North America Sleeping Pills (Prescription Drugs) Sales by Type (2017-2022) & (K Units)
    Table 49. North America Sleeping Pills (Prescription Drugs) Sales by Type (2023-2028) & (K Units)
    Table 50. North America Sleeping Pills (Prescription Drugs) Revenue by Type (2017-2022) & (US$ Million)
    Table 51. North America Sleeping Pills (Prescription Drugs) Revenue by Type (2023-2028) & (US$ Million)
    Table 52. North America Sleeping Pills (Prescription Drugs) Sales by Application (2017-2022) & (K Units)
    Table 53. North America Sleeping Pills (Prescription Drugs) Sales by Application (2023-2028) & (K Units)
    Table 54. North America Sleeping Pills (Prescription Drugs) Revenue by Application (2017-2022) & (US$ Million)
    Table 55. North America Sleeping Pills (Prescription Drugs) Revenue by Application (2023-2028) & (US$ Million)
    Table 56. North America Sleeping Pills (Prescription Drugs) Sales by Country (2017-2022) & (K Units)
    Table 57. North America Sleeping Pills (Prescription Drugs) Sales by Country (2023-2028) & (K Units)
    Table 58. North America Sleeping Pills (Prescription Drugs) Revenue by Country (2017-2022) & (US$ Million)
    Table 59. North America Sleeping Pills (Prescription Drugs) Revenue by Country (2023-2028) & (US$ Million)
    Table 60. Europe Sleeping Pills (Prescription Drugs) Sales by Type (2017-2022) & (K Units)
    Table 61. Europe Sleeping Pills (Prescription Drugs) Sales by Type (2023-2028) & (K Units)
    Table 62. Europe Sleeping Pills (Prescription Drugs) Revenue by Type (2017-2022) & (US$ Million)
    Table 63. Europe Sleeping Pills (Prescription Drugs) Revenue by Type (2023-2028) & (US$ Million)
    Table 64. Europe Sleeping Pills (Prescription Drugs) Sales by Application (2017-2022) & (K Units)
    Table 65. Europe Sleeping Pills (Prescription Drugs) Sales by Application (2023-2028) & (K Units)
    Table 66. Europe Sleeping Pills (Prescription Drugs) Revenue by Application (2017-2022) & (US$ Million)
    Table 67. Europe Sleeping Pills (Prescription Drugs) Revenue by Application (2023-2028) & (US$ Million)
    Table 68. Europe Sleeping Pills (Prescription Drugs) Sales by Country (2017-2022) & (K Units)
    Table 69. Europe Sleeping Pills (Prescription Drugs) Sales by Country (2023-2028) & (K Units)
    Table 70. Europe Sleeping Pills (Prescription Drugs) Revenue by Country (2017-2022) & (US$ Million)
    Table 71. Europe Sleeping Pills (Prescription Drugs) Revenue by Country (2023-2028) & (US$ Million)
    Table 72. Asia Pacific Sleeping Pills (Prescription Drugs) Sales by Type (2017-2022) & (K Units)
    Table 73. Asia Pacific Sleeping Pills (Prescription Drugs) Sales by Type (2023-2028) & (K Units)
    Table 74. Asia Pacific Sleeping Pills (Prescription Drugs) Revenue by Type (2017-2022) & (US$ Million)
    Table 75. Asia Pacific Sleeping Pills (Prescription Drugs) Revenue by Type (2023-2028) & (US$ Million)
    Table 76. Asia Pacific Sleeping Pills (Prescription Drugs) Sales by Application (2017-2022) & (K Units)
    Table 77. Asia Pacific Sleeping Pills (Prescription Drugs) Sales by Application (2023-2028) & (K Units)
    Table 78. Asia Pacific Sleeping Pills (Prescription Drugs) Revenue by Application (2017-2022) & (US$ Million)
    Table 79. Asia Pacific Sleeping Pills (Prescription Drugs) Revenue by Application (2023-2028) & (US$ Million)
    Table 80. Asia Pacific Sleeping Pills (Prescription Drugs) Sales by Region (2017-2022) & (K Units)
    Table 81. Asia Pacific Sleeping Pills (Prescription Drugs) Sales by Region (2023-2028) & (K Units)
    Table 82. Asia Pacific Sleeping Pills (Prescription Drugs) Revenue by Region (2017-2022) & (US$ Million)
    Table 83. Asia Pacific Sleeping Pills (Prescription Drugs) Revenue by Region (2023-2028) & (US$ Million)
    Table 84. Latin America Sleeping Pills (Prescription Drugs) Sales by Type (2017-2022) & (K Units)
    Table 85. Latin America Sleeping Pills (Prescription Drugs) Sales by Type (2023-2028) & (K Units)
    Table 86. Latin America Sleeping Pills (Prescription Drugs) Revenue by Type (2017-2022) & (US$ Million)
    Table 87. Latin America Sleeping Pills (Prescription Drugs) Revenue by Type (2023-2028) & (US$ Million)
    Table 88. Latin America Sleeping Pills (Prescription Drugs) Sales by Application (2017-2022) & (K Units)
    Table 89. Latin America Sleeping Pills (Prescription Drugs) Sales by Application (2023-2028) & (K Units)
    Table 90. Latin America Sleeping Pills (Prescription Drugs) Revenue by Application (2017-2022) & (US$ Million)
    Table 91. Latin America Sleeping Pills (Prescription Drugs) Revenue by Application (2023-2028) & (US$ Million)
    Table 92. Latin America Sleeping Pills (Prescription Drugs) Sales by Country (2017-2022) & (K Units)
    Table 93. Latin America Sleeping Pills (Prescription Drugs) Sales by Country (2023-2028) & (K Units)
    Table 94. Latin America Sleeping Pills (Prescription Drugs) Revenue by Country (2017-2022) & (US$ Million)
    Table 95. Latin America Sleeping Pills (Prescription Drugs) Revenue by Country (2023-2028) & (US$ Million)
    Table 96. Middle East and Africa Sleeping Pills (Prescription Drugs) Sales by Type (2017-2022) & (K Units)
    Table 97. Middle East and Africa Sleeping Pills (Prescription Drugs) Sales by Type (2023-2028) & (K Units)
    Table 98. Middle East and Africa Sleeping Pills (Prescription Drugs) Revenue by Type (2017-2022) & (US$ Million)
    Table 99. Middle East and Africa Sleeping Pills (Prescription Drugs) Revenue by Type (2023-2028) & (US$ Million)
    Table 100. Middle East and Africa Sleeping Pills (Prescription Drugs) Sales by Application (2017-2022) & (K Units)
    Table 101. Middle East and Africa Sleeping Pills (Prescription Drugs) Sales by Application (2023-2028) & (K Units)
    Table 102. Middle East and Africa Sleeping Pills (Prescription Drugs) Revenue by Application (2017-2022) & (US$ Million)
    Table 103. Middle East and Africa Sleeping Pills (Prescription Drugs) Revenue by Application (2023-2028) & (US$ Million)
    Table 104. Middle East and Africa Sleeping Pills (Prescription Drugs) Sales by Country (2017-2022) & (K Units)
    Table 105. Middle East and Africa Sleeping Pills (Prescription Drugs) Sales by Country (2023-2028) & (K Units)
    Table 106. Middle East and Africa Sleeping Pills (Prescription Drugs) Revenue by Country (2017-2022) & (US$ Million)
    Table 107. Middle East and Africa Sleeping Pills (Prescription Drugs) Revenue by Country (2023-2028) & (US$ Million)
    Table 108. Sanofi Corporation Information
    Table 109. Sanofi Description and Major Businesses
    Table 110. Sanofi Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 111. Sanofi Sleeping Pills (Prescription Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. Sanofi Recent Developments
    Table 113. Abbott Laboratories Corporation Information
    Table 114. Abbott Laboratories Description and Major Businesses
    Table 115. Abbott Laboratories Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 116. Abbott Laboratories Sleeping Pills (Prescription Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. Abbott Laboratories Recent Developments
    Table 118. Takeda Pharmaceutical Corporation Information
    Table 119. Takeda Pharmaceutical Description and Major Businesses
    Table 120. Takeda Pharmaceutical Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 121. Takeda Pharmaceutical Sleeping Pills (Prescription Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. Takeda Pharmaceutical Recent Developments
    Table 123. Apotex Corporation Information
    Table 124. Apotex Description and Major Businesses
    Table 125. Apotex Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 126. Apotex Sleeping Pills (Prescription Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. Apotex Recent Developments
    Table 128. Aurobindo Pharma Corporation Information
    Table 129. Aurobindo Pharma Description and Major Businesses
    Table 130. Aurobindo Pharma Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 131. Aurobindo Pharma Sleeping Pills (Prescription Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. Aurobindo Pharma Recent Developments
    Table 133. Actellon Pharmaceuticals Corporation Information
    Table 134. Actellon Pharmaceuticals Description and Major Businesses
    Table 135. Actellon Pharmaceuticals Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 136. Actellon Pharmaceuticals Sleeping Pills (Prescription Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 137. Actellon Pharmaceuticals Recent Developments
    Table 138. Allegiant Health Corporation Information
    Table 139. Allegiant Health Description and Major Businesses
    Table 140. Allegiant Health Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 141. Allegiant Health Sleeping Pills (Prescription Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 142. Allegiant Health Recent Developments
    Table 143. Cayman Chemical Corporation Information
    Table 144. Cayman Chemical Description and Major Businesses
    Table 145. Cayman Chemical Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 146. Cayman Chemical Sleeping Pills (Prescription Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 147. Cayman Chemical Recent Developments
    Table 148. Ambitropin Corporation Information
    Table 149. Ambitropin Description and Major Businesses
    Table 150. Ambitropin Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 151. Ambitropin Sleeping Pills (Prescription Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 152. Ambitropin Recent Developments
    Table 153. Hayao Corporation Information
    Table 154. Hayao Description and Major Businesses
    Table 155. Hayao Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 156. Hayao Sleeping Pills (Prescription Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 157. Hayao Recent Developments
    Table 158. Key Raw Materials Lists
    Table 159. Raw Materials Key Suppliers Lists
    Table 160. Sleeping Pills (Prescription Drugs) Distributors List
    Table 161. Sleeping Pills (Prescription Drugs) Customers List
    Table 162. Sleeping Pills (Prescription Drugs) Market Trends
    Table 163. Sleeping Pills (Prescription Drugs) Market Drivers
    Table 164. Sleeping Pills (Prescription Drugs) Market Challenges
    Table 165. Sleeping Pills (Prescription Drugs) Market Restraints
    Table 166. Research Programs/Design for This Report
    Table 167. Key Data Information from Secondary Sources
    Table 168. Key Data Information from Primary Sources
List of Figures
    Figure 1. Sleeping Pills (Prescription Drugs) Product Picture
    Figure 3. Global Sleeping Pills (Prescription Drugs) Market Share by Type in 2021 & 2028
    Figure 3. Zolpidem Product Picture
    Figure 4. Eszopiclone (Lunesta) Product Picture
    Figure 5. Ramelteon (Rozerem) Product Picture
    Figure 6. Ativan (lorazepam) Product Picture
    Figure 7. Adapin (doxepin) Product Picture
    Figure 8. Global Sleeping Pills (Prescription Drugs) Market Share by Application in 2021 & 2028
    Figure 9. Hospital Pharmacy
    Figure 10. Retail Pharmacy
    Figure 11. Sleeping Pills (Prescription Drugs) Report Years Considered
    Figure 12. Global Sleeping Pills (Prescription Drugs) Sales 2017-2028 (K Units)
    Figure 13. Global Sleeping Pills (Prescription Drugs) Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Sleeping Pills (Prescription Drugs) Revenue 2017-2028 (US$ Million)
    Figure 15. Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 16. Global Sleeping Pills (Prescription Drugs) Sales Market Share by Region (2017-2022)
    Figure 17. Global Sleeping Pills (Prescription Drugs) Sales Market Share by Region (2023-2028)
    Figure 18. North America Sleeping Pills (Prescription Drugs) Sales YoY (2017-2028) & (K Units)
    Figure 19. North America Sleeping Pills (Prescription Drugs) Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Europe Sleeping Pills (Prescription Drugs) Sales YoY (2017-2028) & (K Units)
    Figure 21. Europe Sleeping Pills (Prescription Drugs) Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Asia-Pacific Sleeping Pills (Prescription Drugs) Sales YoY (2017-2028) & (K Units)
    Figure 23. Asia-Pacific Sleeping Pills (Prescription Drugs) Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Latin America Sleeping Pills (Prescription Drugs) Sales YoY (2017-2028) & (K Units)
    Figure 25. Latin America Sleeping Pills (Prescription Drugs) Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Middle East & Africa Sleeping Pills (Prescription Drugs) Sales YoY (2017-2028) & (K Units)
    Figure 27. Middle East & Africa Sleeping Pills (Prescription Drugs) Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. The Sleeping Pills (Prescription Drugs) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 29. The Top 5 and 10 Largest Manufacturers of Sleeping Pills (Prescription Drugs) in the World: Market Share by Sleeping Pills (Prescription Drugs) Revenue in 2021
    Figure 30. Global Sleeping Pills (Prescription Drugs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 31. Global Sleeping Pills (Prescription Drugs) Sales Market Share by Type (2017-2028)
    Figure 32. Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Type (2017-2028)
    Figure 33. Global Sleeping Pills (Prescription Drugs) Sales Market Share by Application (2017-2028)
    Figure 34. Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Application (2017-2028)
    Figure 35. North America Sleeping Pills (Prescription Drugs) Sales Market Share by Type (2017-2028)
    Figure 36. North America Sleeping Pills (Prescription Drugs) Revenue Market Share by Type (2017-2028)
    Figure 37. North America Sleeping Pills (Prescription Drugs) Sales Market Share by Application (2017-2028)
    Figure 38. North America Sleeping Pills (Prescription Drugs) Revenue Market Share by Application (2017-2028)
    Figure 39. North America Sleeping Pills (Prescription Drugs) Sales Share by Country (2017-2028)
    Figure 40. North America Sleeping Pills (Prescription Drugs) Revenue Share by Country (2017-2028)
    Figure 41. U.S. Sleeping Pills (Prescription Drugs) Revenue (2017-2028) & (US$ Million)
    Figure 42. Canada Sleeping Pills (Prescription Drugs) Revenue (2017-2028) & (US$ Million)
    Figure 43. Europe Sleeping Pills (Prescription Drugs) Sales Market Share by Type (2017-2028)
    Figure 44. Europe Sleeping Pills (Prescription Drugs) Revenue Market Share by Type (2017-2028)
    Figure 45. Europe Sleeping Pills (Prescription Drugs) Sales Market Share by Application (2017-2028)
    Figure 46. Europe Sleeping Pills (Prescription Drugs) Revenue Market Share by Application (2017-2028)
    Figure 47. Europe Sleeping Pills (Prescription Drugs) Sales Share by Country (2017-2028)
    Figure 48. Europe Sleeping Pills (Prescription Drugs) Revenue Share by Country (2017-2028)
    Figure 49. Germany Sleeping Pills (Prescription Drugs) Revenue (2017-2028) & (US$ Million)
    Figure 50. France Sleeping Pills (Prescription Drugs) Revenue (2017-2028) & (US$ Million)
    Figure 51. U.K. Sleeping Pills (Prescription Drugs) Revenue (2017-2028) & (US$ Million)
    Figure 52. Italy Sleeping Pills (Prescription Drugs) Revenue (2017-2028) & (US$ Million)
    Figure 53. Russia Sleeping Pills (Prescription Drugs) Revenue (2017-2028) & (US$ Million)
    Figure 54. Asia Pacific Sleeping Pills (Prescription Drugs) Sales Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Sleeping Pills (Prescription Drugs) Revenue Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Sleeping Pills (Prescription Drugs) Sales Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Sleeping Pills (Prescription Drugs) Revenue Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Sleeping Pills (Prescription Drugs) Sales Share by Region (2017-2028)
    Figure 59. Asia Pacific Sleeping Pills (Prescription Drugs) Revenue Share by Region (2017-2028)
    Figure 60. China Sleeping Pills (Prescription Drugs) Revenue (2017-2028) & (US$ Million)
    Figure 61. Japan Sleeping Pills (Prescription Drugs) Revenue (2017-2028) & (US$ Million)
    Figure 62. South Korea Sleeping Pills (Prescription Drugs) Revenue (2017-2028) & (US$ Million)
    Figure 63. India Sleeping Pills (Prescription Drugs) Revenue (2017-2028) & (US$ Million)
    Figure 64. Australia Sleeping Pills (Prescription Drugs) Revenue (2017-2028) & (US$ Million)
    Figure 65. Taiwan Sleeping Pills (Prescription Drugs) Revenue (2017-2028) & (US$ Million)
    Figure 66. Indonesia Sleeping Pills (Prescription Drugs) Revenue (2017-2028) & (US$ Million)
    Figure 67. Thailand Sleeping Pills (Prescription Drugs) Revenue (2017-2028) & (US$ Million)
    Figure 68. Malaysia Sleeping Pills (Prescription Drugs) Revenue (2017-2028) & (US$ Million)
    Figure 69. Philippines Sleeping Pills (Prescription Drugs) Revenue (2017-2028) & (US$ Million)
    Figure 70. Latin America Sleeping Pills (Prescription Drugs) Sales Market Share by Type (2017-2028)
    Figure 71. Latin America Sleeping Pills (Prescription Drugs) Revenue Market Share by Type (2017-2028)
    Figure 72. Latin America Sleeping Pills (Prescription Drugs) Sales Market Share by Application (2017-2028)
    Figure 73. Latin America Sleeping Pills (Prescription Drugs) Revenue Market Share by Application (2017-2028)
    Figure 74. Latin America Sleeping Pills (Prescription Drugs) Sales Share by Country (2017-2028)
    Figure 75. Latin America Sleeping Pills (Prescription Drugs) Revenue Share by Country (2017-2028)
    Figure 76. Mexico Sleeping Pills (Prescription Drugs) Revenue (2017-2028) & (US$ Million)
    Figure 77. Brazil Sleeping Pills (Prescription Drugs) Revenue (2017-2028) & (US$ Million)
    Figure 78. Argentina Sleeping Pills (Prescription Drugs) Revenue (2017-2028) & (US$ Million)
    Figure 79. Middle East and Africa Sleeping Pills (Prescription Drugs) Sales Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Sleeping Pills (Prescription Drugs) Revenue Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Sleeping Pills (Prescription Drugs) Sales Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Sleeping Pills (Prescription Drugs) Revenue Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Sleeping Pills (Prescription Drugs) Sales Share by Country (2017-2028)
    Figure 84. Middle East and Africa Sleeping Pills (Prescription Drugs) Revenue Share by Country (2017-2028)
    Figure 85. Turkey Sleeping Pills (Prescription Drugs) Revenue (2017-2028) & (US$ Million)
    Figure 86. Saudi Arabia Sleeping Pills (Prescription Drugs) Revenue (2017-2028) & (US$ Million)
    Figure 87. U.A.E Sleeping Pills (Prescription Drugs) Revenue (2017-2028) & (US$ Million)
    Figure 88. Sleeping Pills (Prescription Drugs) Value Chain
    Figure 89. Sleeping Pills (Prescription Drugs) Production Process
    Figure 90. Channels of Distribution
    Figure 91. Distributors Profiles
    Figure 92. Bottom-up and Top-down Approaches for This Report
    Figure 93. Data Triangulation
    Figure 94. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Sanofi
Abbott Laboratories
Takeda Pharmaceutical
Apotex
Aurobindo Pharma
Actellon Pharmaceuticals
Allegiant Health
Cayman Chemical
Ambitropin
Hayao
Frequently Asked Questions
Sleeping Pills (Prescription Drugs) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Sleeping Pills (Prescription Drugs) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Sleeping Pills (Prescription Drugs) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Amoxicillin Sodium

Amoxicillin Sodium market is segmented by Type and by Application. Players, stakeholders, and oth ... Read More